Atrial Fibrillation After Patent Foramen Ovale Closure: Innocuous Passerby or Propagating Substrate.
作者信息
Nayak Keshav R, Daniels Matthew J
机构信息
Department of Cardiology, Scripps Mercy, San Diego, California.
Department of Cardiovascular Sciences, University of Manchester, Manchester, United Kingdom.
出版信息
J Soc Cardiovasc Angiogr Interv. 2023 Nov 30;3(1):101218. doi: 10.1016/j.jscai.2023.101218. eCollection 2024 Jan.
Abstract
摘要
相似文献
1
Atrial Fibrillation After Patent Foramen Ovale Closure: Innocuous Passerby or Propagating Substrate.
J Soc Cardiovasc Angiogr Interv. 2023 Nov 30;3(1):101218. doi: 10.1016/j.jscai.2023.101218. eCollection 2024 Jan.
2
Incidence of atrial fibrillation after percutaneous closure of patent foramen ovale and small atrial septal defects in patients presenting with cryptogenic stroke.卵圆孔未闭和小房间隔缺损经皮封堵术后新发心房颤动与隐源性卒中的相关性。
Int J Stroke. 2010 Feb;5(1):4-9. doi: 10.1111/j.1747-4949.2009.00336.x.
3
Are we there yet with patent foramen ovale closure for secondary prevention in cryptogenic stroke? A systematic review and meta-analysis of randomized trials.卵圆孔未闭封堵术用于隐源性卒中二级预防是否已达预期效果？一项随机试验的系统评价和荟萃分析。
SAGE Open Med. 2019 Feb 4;7:2050312119828261. doi: 10.1177/2050312119828261. eCollection 2019.
4
Patent Foramen Ovale Closure for Secondary Prevention of Cryptogenic Stroke: Updated Meta-Analysis of Randomized Clinical Trials.卵圆孔未闭封堵术用于预防隐源性卒中的二级预防：随机临床试验的更新荟萃分析。
Am J Med. 2018 May;131(5):575-577. doi: 10.1016/j.amjmed.2017.11.027. Epub 2017 Dec 8.
5
A matching-adjusted indirect comparison of results from REDUCE and RESPECT-two randomized trials on patent foramen ovale closure devices to prevent recurrent cryptogenic stroke.经调整匹配的间接比较 REDUCE 和 RESPECT 两项随机试验的结果：卵圆孔未闭封堵装置预防隐源性卒中复发。
J Med Econ. 2024 Jan-Dec;27(1):337-343. doi: 10.1080/13696998.2024.2320604. Epub 2024 Feb 29.
6
Changing of Left Atrial Function Index in Symptomatic Patients with Patent Foramen Ovale After Device Closure.症状性房间隔缺损患者经封堵术后左房功能指数的变化。
Turk Kardiyol Dern Ars. 2022 Apr;50(3):175-181. doi: 10.5543/tkda.2022.21027.
7
Transcatheter closure for decompression sickness with a patent foramen ovale: A case report.经导管封堵卵圆孔未闭治疗减压病：一例报告
J Interv Med. 2021 May 20;4(3):149-151. doi: 10.1016/j.jimed.2021.05.004. eCollection 2021 Aug.
8
Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.CLOSURE I（评价 STARFlex 间隔封堵系统在因推测性反常栓塞引起的脑卒中和/或短暂性脑缺血发作的卵圆孔未闭患者中的应用）试验中，不明原因卒中合并卵圆孔未闭患者复发性事件的预测因素。
JACC Cardiovasc Interv. 2014 Aug;7(8):913-20. doi: 10.1016/j.jcin.2014.01.170.
9
Closure of patent foramen ovale in "cryptogenic" stroke: Has the story come to an end?卵圆孔未闭封堵术治疗“隐源性”卒中：故事已经结束了吗？
Int J Stroke. 2018 Apr;13(3):240-242. doi: 10.1177/1747493017751243. Epub 2018 Jan 4.
10
[Detection of secondary atrial fibrillation following percutaneous foramen ovale closure for cryptogenic stroke using an insertable cardiac monitor: a case report].[使用植入式心脏监测仪检测经皮卵圆孔未闭封堵治疗隐匿性卒中后继发性心房颤动：一例报告]
Rinsho Shinkeigaku. 2022 Oct 22;62(10):787-792. doi: 10.5692/clinicalneurol.cn-001781. Epub 2022 Sep 30.
本文引用的文献
1
Safety Outcomes After Percutaneous Transcatheter Closure of Patent Foramen Ovale.经皮导管封堵卵圆孔未闭后的安全性结局
Stroke. 2017 Nov;48(11):3073-3077. doi: 10.1161/STROKEAHA.117.018501. Epub 2017 Sep 22.
2
Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke.卵圆孔未闭封堵或卒中后药物治疗的长期结局。
N Engl J Med. 2017 Sep 14;377(11):1022-1032. doi: 10.1056/NEJMoa1610057.
3
Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke.卵圆孔未闭封堵或抗血小板治疗不明原因卒中。
N Engl J Med. 2017 Sep 14;377(11):1033-1042. doi: 10.1056/NEJMoa1707404.
Zotero 插件